Updated on 21 December 2012
There are other hurdles such as high costs of genetic diagnosis and the data specific to a population is scarce.
The future looks bright
Genetic testing is likely to increase and will be driven by the demand for tailored approaches. A lot of innovation and exciting science is happening in the genetic diagnostics segment. One interesting point to note is that in this relatively new segment of smart healthcare, start-ups are the ones who have taken the lead. One of the reasons behind this could be that a start-up needs to bring novel solutions to the market rather than adding to the exisiting product line.
The companies need to keep in mind that the solutions they offer need to be cost-effective to have a wider reach. The day is not far when a doctor would look at the patient's genome data to prescribe a medicine and start a treatment.